The Dime

Exceptional extraction has long been treated as an art.What separates the best teams is not creativity.It is the ability to repeat quality, consistently.And it is not SOP alone.It is judgment applied consistently under real constraints. Constraints that define what is technically possible, operationally realistic, and economically viable.Those constraints tart with understanding your system and tracking the right operational parameters at a level of detail most teams never reach.That depth of understanding is what allows teams to produce a consistent, high-quality end product instead of relying on feel or memory.This week we sit down with Brian Adams to discussHow to balance SOPs with operator flexibilityHow to think clearly about your extraction system and its limitsWhether rolling back adult use in Massachusetts is real or noise Chapters00:00 The Complexity of Extraction Processes03:06 Adapting SOPs for Optimal Results06:04 Understanding Cost Structures in Extraction09:12 The Importance of Hardware in Product Quality12:07 Navigating Consumer Expectations and Feedback15:10 Quality Control and Brand Reputation18:11 Expanding Product Categories and Maintaining Standards21:07 Educating Consumers on Concentrate Differences23:56 The Future of the Cannabis Industry in Massachusetts30:32 The Current State of Cannabis in Massachusetts34:27 The Threat of Opposition and Industry Response39:55 Navigating Negative Perceptions and Future Outlook41:14 The Importance of Industry Unity and Consumer Education42:29 Engaging with Consumers and Building a BrandSummaryIn this conversation, Bryan Fields and Brian Adams delve into the complexities of extraction processes in the cannabis industry, emphasizing the importance of flexibility in Standard Operating Procedures (SOPs) to achieve optimal results. They discuss the significance of understanding cost structures, the role of hardware in product quality, and the challenges of maintaining brand reputation amidst consumer feedback. The conversation also touches on the need for consumer education regarding concentrate differences and the potential future of the cannabis industry in Massachusetts. In this conversation, Brian Adams discusses the current challenges facing the cannabis industry in Massachusetts, particularly in light of recent negative news and opposition movements. He emphasizes the need for industry unity to combat misinformation and protect the rights of consumers. The discussion also touches on the importance of educating consumers about cannabis production and the potential impact of regulatory changes on the industry.Guest Links:https://www.nimbuscannabisco.com/https://www.nimbuscannabisco.com/Our Linkshttps://www.nimbuscannabisco.com/https://www.instagram.com/nimbuscc/https://www.linkedin.com/company/nimbus-cannabis-co/https://www.linkedin.com/company/hudson-botanical-processing/https://www.linkedin.com/in/jb-adams/Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Most cannabis automation fails for a simple reason.It optimizes motion instead of understanding.Automation executes. Robotics adapts.That distinction matters in an industry where variability is unavoidable and capital is limited.This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing.This week, we sit down with Nohtal Partansky to cover:Why automation breaks under variabilityAutomation vs robotics, clearly definedHow to avoid expensive missteps Chapters00:00 Understanding Automation in Cannabis Manufacturing03:02 The Role of Robotics vs. Automation05:45 Consultative Approach to Automation08:54 Challenges in Cultivation Automation11:59 Designing for Variability in Automation15:01 Iterative Development and Customer Feedback18:08 Identifying Design vs. Customer Issues21:06 Adapting to Environmental Nuances23:55 Conveying Value in Automation Solutions27:09 Strategic Approaches to Automation in Supply Chain30:10 Optimizing Pre-Roll Production Processes33:44 Understanding Tolerance Levels in Manufacturing36:39 Intellectual Property in the Cannabis Industry42:26 Innovations in Cannabis Manufacturing45:32 Challenges in Automation and Scaling50:51 Improving Processes and Training in Cannabis OperationsSummaryIn this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry.Guest Linkshttps://www.instagram.com/sortingroboticsinc/https://www.youtube.com/@sortingroboticshttps://www.linkedin.com/company/sortingrobotics/https://www.sortingrobotics.com/https://www.linkedin.com/in/nohtal/Our LinksBryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaunty’s rise to the top of the New York cannabis market was not an overnight success.It was built through discipline in a market uniquely designedNew York’s rollout remains unforgiving.One store openings, supply and demand constraints, and continuous price compression forced every decision into the open.This week we sit down with Nicolas Guarino, Co-Founder and CEO of Jaunty, to break down what it actually takes to survive and scale in one of the most interesting cannabis markets in the country.This week we sit down with Nick to discuss:Why consistency becomes the only real moat as prices fallHow New York’s rollout punished assumptions and rewarded preparednessCapital discipline, supplier trust, and avoiding overspend death spiralsChapters00:00 Introduction to Jaunty and Nicolas Guarino03:06 The Journey into the Cannabis Industry06:07 Challenges and Lessons Learned in CBD09:00 Transitioning to Recreational Cannabis11:54 Building a Brand in a Competitive Market15:07 Navigating Market Dynamics and Growth Challenges18:07 The Importance of Support and Resilience20:49 Understanding Market Economics and Consumer Behavior23:55 Future Prospects for Cannabis in New York31:48 The Economics of Cannabis Production36:29 The Importance of Consistency in Branding41:11 Navigating Challenges in Cannabis Operations46:10 Strategic Planning for Future Growth51:56 Inventory Management and Cost Control56:02 Preparing for Market Consolidation58:11 Final Thoughts and Future Directions About: Nicolas Guarino is Co-Founder and CEO of Jaunty. As a GMP-certified 100% New York company working in cannabis extraction since 2017, Jaunty has been producing and distributing the finest solventless hash, live resin, and distillate cannabis products in its mission to close the gap between flower and oil. With state-of-the-art manufacturing facilities in Hoosick Falls, NY, Jaunty is one of New York's leading companies licensed for all adult-use cannabis supply chain activities outside of retail, including cultivation, processing, manufacturing, and distribution. They produce and distribute one of New York’s best-selling cannabis vape brands, available in all of the state’s licensed dispensaries, and their product portfolio also features gummies, concentrates, and disposable vapes.SummaryIn this episode, Bryan Fields interviews Nicolas Guarino, co-founder and CEO of Jaunty, discussing his journey in the cannabis industry, the challenges faced in the CBD market, and the transition to recreational cannabis. They explore the importance of brand consistency, financial strategies for growth, and the dynamics of the New York cannabis market. Nicholas shares insights on consumer education, market predictions, and the future vision for Jaunty emphasizing the need for adaptability and resilience in a fast-paced industry.Guest Linkshttps://jaunty.com/https://x.com/getjauntyhttps://www.linkedin.com/company/get-jauntyhttps://www.instagram.com/get_jaunty/https://www.linkedin.com/in/nicolas-guarino-43939b103/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Before CBD was discussed by a President in the Oval Office, it was a medical necessity.The Charlotte Figi story is well documented — and powerful.Not because it was emotional, but because it forced a serious medical conversation.Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.This week, we sit down with Bill Morachnick to break down:Why CBD earned acceptance through medical trust, not consumer marketingHow physician comfort, reimbursement pathways, and standards changed the conversationCBD in the Oval Office — and what that signals for the future of cannabis Chapters00:00 Introduction to Charlotte's Web and Bill Morachnick03:00 The Inspiring Story of Charlotte Figi05:51 The Executive Order and Its Implications08:59 The Role of Education in CBD Acceptance12:12 Challenges and Misconceptions in the Cannabis Industry15:03 The Future of CBD and Medical Recommendations18:06 The Impact of Federal Reimbursement on CBD21:08 Defloria and the Future of Cannabis Research24:01 Navigating Regulatory Changes and Industry Challenges27:03 The Importance of Quality and Consistency in CBD Products30:02 The Potential for Pharmaceutical Collaborations33:04 Looking Ahead: The Future of CBD and Cannabis36:13 Final Thoughts and Audience EngagementSummaryIn this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.Guest Links:https://www.trycharlottesweb.com/https://www.charlottesweb.com/https://www.youtube.com/charlotteswebcbdhttps://www.instagram.com/charlotteswebcbd/https://www.linkedin.com/in/bill-morachnick-01318a6/https://www.linkedin.com/company/charlottesweb/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Everyone wants their product and brand to be known for consistency .Almost no one is willing to do the difficult work that makes consistency possible.This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lastsHow MariMed engineers consistency across states by centralizing inputs & testing aggressively,What it actually takes to make effects-based products consistent and repeatable Chapters00:00 Introduction to the Cannabis Industry and Edibles03:05 The Evolution of Edibles: From Early Days to Now06:01 Ensuring Consistency Across State Lines09:09 Quality Control and Testing in Edibles12:01 Consumer Education and Brand Trust15:13 MariMed Brand Portfolio and Market Strategy18:06 Role of R&D in Product Development21:00 Future Trends and Innovations in Edibles24:03 Building Relationships with Budtenders and Consumers27:58 Exploring Cannabinoids: THCV and CBG Effects30:06 Understanding Edible Experiences and Consumer Expectations32:00 Responsible Product Development in the Cannabis Industry33:52 Brand Strategy and Market Penetration in New States35:51 Innovative Products: Vibations and Consumer Convenience38:04 Navigating the Hemp Market and Brand Expansion39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis44:02 The Importance of Team and Company CultureGuest Links:https://www.marimedinc.com/https://www.linkedin.com/company/marimed-inc/about/https://www.linkedin.com/in/ryan-crandall-43133b12/https://x.com/MariMed_IncSummaryIn this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Schedule III isn’t the finish line.It’s the starting gun.The EO said a lot — but most operators aren’t ready for what it actually means.This week we sit down with Zach Edge and Dr. Matthew Moore to break down:Why Schedule III is guidance, not rules — and why the real impact comes during rulemakingWhat GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operatorsWhich parts of the supply chain face the biggest disruption as cannabis moves forwardChapters00:00 Historic Changes in Cannabis Scheduling03:13 The Impact of Hemp in the New Landscape06:07 Strategic Shifts for Cannabis Operators08:59 Navigating Regulatory Changes11:58 The Role of Pharmacies in the New Market15:04 Global Trade and Competition in Cannabis17:53 Research Opportunities and Challenges21:02 Veterans and the Future of CBD24:02 The Supply Chain Dynamics26:47 The Future of Hemp and CBD Products29:56 Final Thoughts on the Cannabis Industry Summary:In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves. Guest Links:https://www.linkedin.com/company/the-rho-advisory/https://www.linkedin.com/in/zach-edge/https://www.linkedin.com/in/mmoore09/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

SNDL is much bigger than most people realize — with global distribution, massive extraction capacity, and a diversified retail and manufacturing engine that touches nearly every part of the cannabis supply chain.This week we sit down with Tyler Robson, President of SNDL, to break down:• How SNDL became a global manufacturing and retail powerhouse• Why extraction and derivatives are their true competitive edge• How they operate across countries with completely different rules and product formatsChapters00:00 Introduction to Sundial and Tyler Robson02:08 The Complexity of Extraction and Manufacturing04:38 Merging Sundial and Valens: Challenges and Strategies06:11 Sundial's Operations and Global Reach07:39 Firefighting and Problem Solving in Leadership09:52 Data-Driven Decision Making12:44 Navigating Different Regulatory Environments13:55 Core Competencies and Operational Efficiencies15:46 Staying Focused in a Distracted Industry16:18 Sundial's Market Position and Brand Partnerships17:10 Strategic Focus on Texas and Florida19:09 Resource Planning and Flexibility20:42 Continuous Improvement in Manufacturing22:34 Synergies Between Liquor and Cannabis24:48 Future of Cannabis and Liquor Co-Mingling26:30 Emerging International Markets28:23 Potential Partnerships and Collaborations30:08 The Size of the Global Cannabis Opportunity31:31 Strategic Partnerships in the US32:03 Conclusion and Key TakeawaysSummaryIn this episode, Tyler Robson, president of Sundial, shares insights into his journey in the cannabis industry, the complexities of extraction and manufacturing, and the challenges of merging companies. He discusses Sundial's global operations, the importance of data-driven decision making, and the need for focus in a distracted industry. Tyler also highlights the potential for growth in emerging markets and the synergies between the cannabis and liquor industries, while emphasizing the significance of strategic partnerships.Guest Links:https://sndl.com/homepage/default.aspxhttps://www.linkedin.com/in/tyler-robson-a77ba4155/https://www.linkedin.com/company/sndlinc/investors@sndl.comOur Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Most operators think debt is dangerous. But what if the real problem is how we think about it?The opposite is true: when used correctly, debt is the single biggest growth lever in cannabis. Every major industry scales on borrowed capital — cannabis is the only one still trying to do it alone.This week we sit down with Adam Stettner to discuss:• Why debt — used properly — compounds growth• The difference between smart leverage and over-leverage• How operators can fix cash-flow bottlenecks and scale predictablyChapters00:00 Introduction to Adam Stettner and FundCanna.03:05 Adam's Journey into the Cannabis Industry06:12 Understanding Underwriting in Cannabis Financing09:05 The Importance of Client-Centric Financing11:56 Navigating Complex Variables in Cannabis Lending14:57 Building Infrastructure for Cannabis Financing17:48 Segmenting the Cannabis Industry for Better Insights20:55 The Unique Challenges of Cannabis Lending24:12 The Role of Transparency in Client Relationships28:23 Building Partnerships for Success29:29 Funding Options for Operational Efficiency32:29 Understanding Technology and Business Operations37:54 Navigating Debt and Financial Strategies42:10 Using Debt to Accelerate Growth52:46 Exploring Funding OpportunitiesSummaryIn this episode, Bryan Fields and Kellen Finney welcome Adam Stettner, CEO of FundCanna, to discuss the complexities of cannabis financing. Adam shares his journey from the apparel industry to cannabis, emphasizing the importance of understanding the unique challenges of underwriting in this space. He highlights the need for a client-centric approach in lending, the significance of transparency, and the innovative strategies FunCounter employs to navigate the cannabis market. Adam also discusses the importance of knowledge sharing and the metrics that indicate success in cannabis financing. In this conversation, Adam Stettner discusses the importance of building partnerships in the cannabis industry, focusing on how funding can enhance operational efficiency and support business growth. He emphasizes the need for flexible financial solutions that allow businesses to thrive without being constrained by debt. Stettner also highlights the significance of understanding technology and its impact on business operations, advocating for a metrics-based approach to financial decisions. The discussion concludes with insights on leveraging debt as a tool for growth and the importance of fostering relationships in the industry.  Guest Links:https://fundcanna.comhttps://fundcanna.com/about/adam-stettner/https://www.linkedin.com/in/adamstettnerhttps://www.linkedin.com/company/fundcanna/About Adam Stettner:Adam has 30 years of business, strategy and leadership experience in both Private and Public Companies. In 2021, Adam believed the timing and opportunity was right for him to bring his passion for business, innovative financing and entrepreneurial spirit to the Cannabis sector by creating funding products for all areas of this early stage, growth industry by founding FundCanna. FundCanna provides short term funding to all areas of the sector; cultivators, manufacturers, vendors, suppliers, distributors and retailers. In just its first year, FundCanna has underwritten roughly 3000 files and funded over 500 unique files bringing much needed liquidity and financing solutions to the legal Cannabis industry.Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Everyone in cannabis talks about effects-based products — almost no one can deliver them consistently.Repeatable experiences require precision and formulation discipline that looks a lot more like pharma than cannabis.And here’s why: most operators don’t treat in-house analytics as essential. But that’s the mistake.Process control isn’t optional — it’s the foundation for delivering the same experience every single time.This week we sit down with Chris Emerson, Founder of LEVEL, to break down:• How true effects-based products are actually built• The analytics and standardization required for repeatability• Why most teams can’t achieve consistency — and what it takes to fix it Chapters00:00 Introduction to Chris Emerson and Level03:07 The Journey into Cannabis and Product Development06:02 Challenges in Consistency and Formulation08:48 Navigating the Market and Consumer Education12:05 The Role of Cannabinoids and Future Innovations14:56 Expanding Beyond California: Challenges and Strategies27:32 The Importance of Consistency in Product Quality29:51 Navigating the Medical vs Recreational Cannabis Landscape33:03 Advanced Analytics in Cannabis Production36:02 Innovations in Product Formulation and Consumer Experience39:56 Strategic Approaches to Hemp and Cannabinoid Research45:00 Exploring the Future of Cannabinoids and Consumer Education SummaryIn this conversation, Chris Emerson, founder of Level, shares his journey from academia to the cannabis industry, discussing the challenges and innovations in product development. He emphasizes the importance of effects-based formulations, consistency in product quality, and the need for consumer education in a rapidly evolving market. The discussion also touches on the future of cannabinoid products and the strategies for expanding into new markets while maintaining quality and consistency. In this conversation, Chris Emerson discusses the complexities of cannabis production, emphasizing the importance of consistency and advanced analytics in ensuring product quality. He explores the challenges faced by the medical cannabis market as it competes with recreational use, and shares insights on the evolving landscape of cannabinoid research, particularly focusing on the Varin class and acidic cannabinoids. The discussion also touches on strategic approaches to hemp and the significance of consumer education in navigating the cannabis industry.Guest Links:https://www.linkedin.com/in/chris-emerson-ph-d-464b245a/https://www.instagram.com/level.experiencehttps://www.linkedin.com/company/levelexperience/https://levelexperience.com/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tobacco and alcohol are already laying the groundwork for cannabis — building IP, infrastructure, and data.Nick Kenney breaks down what legacy industries already understand — how regulated markets are built, and why readiness always beats speed.This week we sit down with Nick Kenny to discuss:• How tobacco and alcohol are entering cannabis• The playbook for building standardized, scalable systems• Why predictability and timing will define the next wave of winnersChapters00:00 Introduction to the Cannabis Industry Journey02:54 The Evolution of Cannabis Perception06:02 Navigating Regulatory Challenges08:48 Tobacco and Alcohol Industry Perspectives11:59 The Role of Research and Development14:58 Long-Term Strategies vs. Short-Term Survival18:10 Consumer Behavior and Market Trends21:03 The Importance of Data in Decision Making23:58 Collaboration and Networking in the Industry27:04 Future Outlook and Industry InnovationsSummaryIn this episode, Bryan Fields and Kellan Finney engage with Nick Kenney, a Global Strategic Advisor, to explore the evolving landscape of the cannabis industry. Nick shares his journey from the tobacco sector to cannabis, highlighting the significant shifts in perception and investment within the industry. The conversation delves into the regulatory challenges, the perspectives of tobacco and alcohol companies, and the importance of research and development. They discuss the need for long-term strategies, the impact of consumer behavior, and the critical role of data in decision-making. Nick emphasizes the value of networking and collaboration in the cannabis space, while also providing insights into future innovations and market trends.Guest Links:https://www.kbsstrategicadvisors.com/https://www.linkedin.com/company/kbsstrategicadvisory/https://www.linkedin.com/in/nicholasjkenny/Our Links:Bryan Fields on TwitterKellan Finney on TwitterThe Dime on TwitterExtraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.The Dime is a top 5% most shared  global podcastThe Dime is a top 10 Cannabis Podcast The Dime has a New Website. Shhhh its not finished.🎥 YouTube:  The Dime📸 Instagram:  The Dimehttps://www.newton-insights.com/ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.